Antioxidants reduce the mutagenic effect of malonaldehyde and beta-propiolactone. Part IX. Antioxidants and cancer

Mutat Res. 1979 Apr;66(4):349-55. doi: 10.1016/0165-1218(79)90045-4.

Abstract

Increasing concentrations of malonaldehyde and beta-propiolactone were increasingly mutagenic with 7 mutants of Salmonella typhimurium, 5 of which mutated bya frameshift mechanism and 2 of which mutated through base-pair substitution. The antioxidants vitamin C, vitamin E, selenium and butylated hydroxytoluene (BHT) at 3 logarithmic concentrations markedly reduced mutagenesis in those strains which mutated by frameshift mechanism.

MeSH terms

  • Ascorbic Acid / pharmacology
  • Butylated Hydroxytoluene / pharmacology
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical
  • Genetic Techniques
  • Lactones / pharmacology*
  • Malonates / pharmacology*
  • Malondialdehyde / pharmacology*
  • Mutagens* / antagonists & inhibitors
  • Propiolactone / pharmacology*
  • Salmonella typhimurium / genetics
  • Selenium / pharmacology
  • Vitamin E / pharmacology

Substances

  • Lactones
  • Malonates
  • Mutagens
  • Vitamin E
  • Butylated Hydroxytoluene
  • Malondialdehyde
  • Propiolactone
  • Selenium
  • Ascorbic Acid